<DOC>
	<DOCNO>NCT00691886</DOCNO>
	<brief_summary>To achieve safe , consistent , continuous sedation use Dexmedetomidine advaced bronchoscopy procedure may reduce need rapid pain sedative infusion .</brief_summary>
	<brief_title>Safety Efficacy Intravenous ( IV ) Dexmedetomidine During Flexible Bronchoscopy Endobronchial Ultrasound</brief_title>
	<detailed_description>Dexmedetomidine hydrochloride single agent produce sedation , pain relief , anxiety redution , stable respiratory rate , predictable cardiovascular response . Dexmedetomidine facilitate patient comfort , compliance comprehension offer sedation ability awaken patient . This study do determine sedation efficacy dosing ; measure reduction eliminate need rapid sedative infusion bronchoscopy ; improvement patient comfort safety complex bronchoscopy ; establish new paradigm moderate sedation flexible bronchoscopy</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Adults age 18 85 Adults schedule flexible brochoscopy use EUBS ( Endobronchial Ultrasound ) Sever bradycardia ( rate &lt; 50 ) / relate bradydysrhymias ( e.g . advanced heart block ) Impaired ventricular function ( EF &lt; 30 % ) Hypovolemia hypotension ( SBP &lt; 90 MAP &lt; a55 ) Have GFR less 15ml/min 1.73m2 undergoing hemodialysis Endstage liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>sedation</keyword>
</DOC>